ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 6, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13755427. The replay will be available until November 13, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations...

AS Tallink Grupp will introduce the results of the third quarter of 2025 in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 23 October 2025 at 12:00 (EEST). The webinar will be held in English. The financial results will be presented by Margus Schults, the Member of the Management Board . We kindly ask participants to provide their questions before the webinar, latest by 11:00 am on 23 October 2025, by e-mail to: investor@tallink.ee. Due to time constraint, preference will be given to questions submitted in writing before the webinar. How to join the webinar?The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. To participate, please join the webinar on 23 October...

AS Tallink Grupp will introduce the results of the third quarter of 2025 in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 23 October 2025 at 12:00 (EEST). The webinar will be held in English. The financial results will be presented by Margus Schults, the Member of the Management Board . We kindly ask participants to provide their questions before the webinar, latest by 11:00 am on 23 October 2025, by e-mail to: investor@tallink.ee. Due to time constraint, preference will be given to questions submitted in writing before the webinar. How to join the webinar?The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. To participate, please join the webinar on 23 October...

Preliminary Financial Results and Business Update for the Quarter Ended September 30, 2025 SPRINGFIELD, Mo., Oct. 15, 2025 (GLOBE NEWSWIRE) — Great Southern Bancorp, Inc. (the “Company”) (NASDAQ:GSBC), the holding company for Great Southern Bank (the “Bank”), today reported that preliminary earnings for the three months ended September 30, 2025, were $1.56 per diluted common share ($17.8 million net income) compared to $1.41 per diluted common share ($16.5 million net income) for the three months ended September 30, 2024. For the quarter ended September 30, 2025, annualized return on average common equity was 11.30%, annualized return on average assets was 1.23%, and annualized net interest margin was 3.72%, compared to 11.10%, 1.11% and 3.42%, respectively, for the quarter ended September 30, 2024. Third Quarter 2025 Key Results:Net...

CONWAY, Ark., Oct. 15, 2025 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“Home” or the “Company”), parent company of Centennial Bank, released quarterly earnings today. Quarterly Highlights Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024Net income $123.6 million $118.4 million $115.2 million $100.6 million $100.0 millionNet income, as adjusted (non-GAAP)(1) $119.7 million $114.6 million $111.9 million $99.8 million $99.0 millionTotal revenue (net) $277.7 million $271.0 million $260.1 million $258.4 million $258.0 millionIncome before income taxes $159.3 million $152.0 million $147.2 million $129.5 million $129.1 millionPre-tax, pre-provision, net income (PPNR) (non-GAAP)(1) $162.8 million $155.0 million $147.2 million $146.2 million $148.0 millionPPNR, as adjusted (non-GAAP)(1) $157.7 million $150.4...

LISLE, Ill., Oct. 15, 2025 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) will release its earnings for the third quarter 2025 at approximately 8:00 a.m. (ET) on Tuesday, October 28, 2025. A conference call to discuss third quarter 2025 results with management is scheduled for Tuesday, October 28, 2025 at 10:00 a.m. (ET). The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-646-844-6383 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location. The passcode is 815166. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://investors.ctscorp.com/news-events/events-and-presentations/ where it will be archived for...

Financial and Operating HighlightsNet income attributable to common stockholders of $0.34 per share for the third quarter of 2025 as compared to net loss of $0.21 per share for the same period in 2024. Funds from operations (“FFO”) of $1.58 per share for the third quarter of 2025, net of transaction costs of $13.1 million, or $0.17 per share, primarily related to the Company’s pursuit of a gaming license. The Company reported FFO of $1.13 per share for the same period in 2024. Signed 52 Manhattan office leases totaling 657,942 square feet in the third quarter of 2025 and 143 Manhattan office leases totaling 1,801,768 square feet for the first nine months of 2025. The mark-to-market on signed Manhattan office leases was 2.7% lower for the third quarter and 1.1% lower for the first nine months of 2025 than the previous...

WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company’s unaudited financial statements for the three and six months ended June 30, 2025, are available at https://investor.eagleus.com/events-presentations. About Eagle Pharmaceuticals, Inc.Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and BYFAVO® and BARHEMSYS® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes...

Management to discuss third quarter 2025 results and host investor Q&A at virtual eventeXp World Holdings to Announce Third Quarter 2025 Results on November 6, 2025Management to discuss third quarter 2025 results and host investor Q&A at virtual eventBELLINGHAM, Wash., Oct. 15, 2025 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced it expects to report its third quarter 2025 financial results on Thursday, November 6, 2025. The Company will hold a virtual fireside chat and investor Q&A on Thursday, November 6, 2025 at 2 p.m. PT / 5 p.m. ET hosted by:Glenn Sanford, Founder, Chairman and CEO, eXp World Holdings Leo Pareja, CEO, eXp Realty Wendy Forsythe, CMO, eXp Realty Jesse Hill, Chief Financial Officer,...

DALLAS, Oct. 15, 2025 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (NYSE: TFIN) has released its third quarter 2025 financial results. The 3Q 2025 financial results and shareholder letter are available on the Company’s website at ir.triumph.io through the News & Events, Events & Presentations links. Aaron P. Graft, Vice Chairman & CEO, and Brad Voss, CFO, will review the financial results in a conference call with investors and analysts beginning at 9:30 a.m. central time on Thursday, October 16, 2025. The live video conference option may be accessed directly through this link, https://triumph-financial-q3-2025-earnings.open-exchange.net/ or via the Company’s IR website at ir.triumph.io through the News & Events, Events & Presentations links. An archive of this conference call will subsequently be available...